nifekalant hydrochloride has been researched along with halothane in 2 studies
Studies (nifekalant hydrochloride) | Trials (nifekalant hydrochloride) | Recent Studies (post-2010) (nifekalant hydrochloride) | Studies (halothane) | Trials (halothane) | Recent Studies (post-2010) (halothane) |
---|---|---|---|---|---|
138 | 16 | 38 | 14,369 | 884 | 235 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Awaji, T; Haruno, A; Hashimoto, K; Hirasawa, A; Wu, Z; Xue, Y | 1 |
Hashimoto, K; Noda, Y | 1 |
2 other study(ies) available for nifekalant hydrochloride and halothane
Article | Year |
---|---|
Effects of the new class III antiarrhythmic drug MS-551 and d-sotalol on canine coronary ligation-reperfusion ventricular arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Female; Halothane; Ligation; Male; Myocardial Reperfusion; Pentobarbital; Pyrimidinones; Sotalol; Ventricular Fibrillation | 1995 |
Development of a halothane-adrenaline arrhythmia model using in vivo Guinea pigs.
Topics: Adrenergic alpha-Agonists; Anesthetics, Inhalation; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Diltiazem; Electrocardiography; Epinephrine; Guinea Pigs; Halothane; Long QT Syndrome; Male; Pyrimidinones; Vagotomy | 2004 |